Cargando…
Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells
BACKGROUND: Hepatocellular carcinoma (HCC) is an aggressive cancer, and is the third leading cause of cancer death worldwide. Standard therapy is ineffective partly because HCC is intrinsically resistant to conventional chemotherapy. Its poor prognosis and limited treatment options make it critical...
Autores principales: | Wei, Wei, Chua, Mei-Sze, Grepper, Susan, So, Samuel K |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2759906/ https://www.ncbi.nlm.nih.gov/pubmed/19778454 http://dx.doi.org/10.1186/1476-4598-8-76 |
Ejemplares similares
-
Soluble Frizzled-7 receptor inhibits Wnt signaling and sensitizes hepatocellular carcinoma cells towards doxorubicin
por: Wei, Wei, et al.
Publicado: (2011) -
Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells
por: Ma, Li, et al.
Publicado: (2015) -
Suppression of ATAD2 inhibits hepatocellular carcinoma progression through activation of p53- and p38-mediated apoptotic signaling
por: Lu, Wen-Jing, et al.
Publicado: (2015) -
NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation
por: Lu, Wen-Jing, et al.
Publicado: (2015) -
A Humanized Anti-GPC3 Antibody for Immuno-Positron Emission Tomography Imaging of Orthotopic Mouse Model of Patient-Derived Hepatocellular Carcinoma Xenografts
por: Natarajan, Arutselvan, et al.
Publicado: (2021)